Long pentraxin 3 as a marker of COVID-19 severity: evidences and perspectives

Roberto Assandri1, Silvia Accordino2, Ciro Canetta2

  • 1Clinical Investigation Laboratory, Ospedale Maggiore di Crema, Crema, Italy.

Biochemia Medica
|April 25, 2022
PubMed

Insights

High levels of Pentraxin 3 (PTX3) accurately predict severe Coronavirus Disease 2019 (COVID-19) and the need for intensive care unit (ICU) admission. PTX3 is a more reliable indicator than standard laboratory tests.

Area of Science:

  • Biochemistry
  • Immunology
  • Critical Care Medicine

Background:

  • Coronavirus Disease 2019 (COVID-19) presents with varied laboratory abnormalities, often insufficient for predicting disease severity.
  • The long pentraxin 3 (PTX3) is an inflammatory marker released at inflammation sites, previously linked to severity in other inflammatory conditions.

Purpose of the Study:

  • To evaluate Pentraxin 3 (PTX3) as a predictive marker for COVID-19 severity.
  • To compare the efficacy of PTX3 in identifying severe COVID-19 cases against routine laboratory parameters.

Main Methods:

  • Retrospective analysis of serum samples from RT-PCR confirmed COVID-19 patients at hospital admission.
  • Measurement of Pentraxin 3 (PTX3) using enzyme-linked immunosorbent assay (ELISA).
  • Intensive care unit (ICU) stay was used as a surrogate endpoint for severe COVID-19.

Main Results:

  • Pentraxin 3 (PTX3) levels were significantly higher in ICU patients compared to non-ICU patients (35.86 vs. 10.61 ng/mL, P < 0.001).
  • PTX3 was the sole significant laboratory predictor of ICU stay in multivariate analysis (OR: 1.68, P = 0.003).
  • PTX3 demonstrated superior accuracy (AUC = 0.98) in identifying ICU patients compared to C-reactive protein (CRP), lactate dehydrogenase (LD), and ferritin.

Conclusions:

  • Elevated Pentraxin 3 (PTX3) levels are indicative of severe Coronavirus Disease 2019 (COVID-19).
  • PTX3 serves as a highly accurate biomarker for predicting the need for intensive care unit (ICU) admission in COVID-19 patients.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
476
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
237
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
41
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
31
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
216